Faculty Profile: Lynn Taylor, MD

Lynn Taylor, MD
Assistant Professor of Medicine
Medicine
Work: 793-4705
Lynn E. Taylor, M.D., is an HIV specialist focusing on HIV and viral hepatitis coinfection. Her research involves extending hepatitis C virus (HCV) care to persons with HIV and co-existing psychiatric and substance disorders, and improving HCV screening, diagnosis and treatment uptake. Dr. Taylor is among the first to investigate incident HCV infection in several large U.S. cohorts of HIV-infected persons, including cohorts of the Adult AIDS Clinical Trials Group (ACTG), and CDC-sponsored SUN Study. She has developed several lines of research to investigate the emerging epidemic of sexually transmitted HCV among HIV-infected men who have sex with men.

Biography

Lynn E. Taylor, MD, is an HIV specialist focusing on HIV and viral hepatitis coinfection. She developed and directs Miriam Hospital's HIV/Viral Hepatitis Coinfection Program, providing multidisciplinary care to HIV/hepatitis C virus (HCV) and HIV/hepatitis B coinfected persons. Her research involves extending HCV care to persons with HIV and co-existing psychiatric and substance disorders, and improving HCV screening, diagnosis and treatment uptake. After graduating from Harvard, Dr. Taylor worked for five years in women's health, public health and advocacy before entering The University of Pittsburgh School of Medicine. She completed Internship/Residency in General Internal Medicine at Brown University/RI Hospital, and an NIH/NIDA T32 Research Fellowship at Miriam Hospital/Brown University on prevention, diagnosis and treatment of HIV and viral hepatitis among substance users. Dr. Taylor developed and directs, "Make it HAPPEN: Hepatitis Awareness, Prevention, Policy and Education Network," establishing RI's first free viral hepatitis testing, counseling, referral and vaccination sites.

Institutions

Mh

Research Description

In 2008 Dr. Taylor received a five-year Mentored Patient-Oriented Clinical Research Award from NIH/NIDA (1 K23 DA020383-01) entitled, "Buprenorphine as a Bridge to hepatitis C virus (HCV) Treatment for HIV/HCV Coinfected Opioid Users." The goals of this research were to explore the impact of drug use on the ability of HIV/HCV coinfected individuals to engage in HCV treatment, to design and implement studies to improve health services delivery for HIV/HCV coinfected drug users, and to develop treatment interventions to limit morbidity and mortality of those at highest risk for HCV disease progression. Dr. Taylor was Co-Director, Hepatitis and Liver Function Core, of the Brown/Tufts Center for Drug Abuse and AIDS Research (CDAAR) which aimed to enhance basic, clinical, epidemiological, prevention and applied research on drug abuse and HIV infection through the support of shared resources. The Hepatitis and Liver Disease Core was implemented to stimulate and facilitate research on HIV, drug abuse, viral hepatitis and resultant liver disease.

Dr. Taylor is among the first to investigate incident HCV infection in several large U.S. cohorts of HIV-infected persons, including cohorts of the Adult AIDS Clinical Trials Group (ACTG), and CDC-sponsored SUN Study. She has developed several lines of research to investigate the emerging epidemic of sexually transmitted HCV among HIV-infected men who have sex with men. Dr. Taylor was Principal Investigator of the Lifespan/Tufts/Brown Center for AIDS Research (CFAR) pilot study, "Screening for Acute Hepatitis C Virus Among At Risk HIV+ Populations," to develop, implement and evaluate a screening strategy for acute HCV infection among at-risk patients in an HIV clinic based on risk factors and ALT, and to estimate acute HCV incidence. She received a Rhode Island Foundation Medical Research Grant entitled, "Identifying Acute Hepatitis C Virus among At-Risk-Hard-to-Reach Populations."

Dr. Taylor was Principal Investigator of, "Caring for HCV at Methadone Programs (CHAMP)," to investigate HCV treatment in HIV/HCV coinfected persons on methadone. She was awarded a Lifespan Developmental grant to design, implement, and evaluate a pilot intervention to treat HCV in HIV/HCV coinfected persons with comorbid substance and psychiatric disorders.

Dr. Taylor collaborates with community-based agencies to expand viral hepatitis and HIV testing in Rhode Island. Her commitment to community-based HIV and viral hepatitis care involves serving since 2005 as Managing Physician for AIDS Care Ocean State Adult Services (ACOS), Rhode Island's only Community Based Organization solely dedicated to the care of persons with and at risk of HIV infection. ACOS runs Rhode Island's needle exchange program, ENCORE.

Dr. Taylor also receives grants on behalf of MomDocFamily http://biomed.brown.edu/owims/MomDocFamily to develop lactation spaces in hospitals to support physicians who are mothers.

Grants and Awards

1994-1995, 1995-1996 National Health Service Corps Scholarship, United States Department of Health and Human Services, Public Health Service, Bureau of Primary Care

1996-1997 Morris H. and Gertrude M. Harris Foundation Scholarship

May 1997 C. F. Reynolds Medical History Society Award for a Study of the History of Kaposi's Sarcoma

May 2000 Brown University School of Medicine M.D. Class of 2000 Resident Teaching Award
" ÃÆ'Ã'¢Ã¢'Ã'¬Ã'Ã'¦for an unwavering respect for all the people ÃÆ'Ã'¢Ã¢'Ã'¬" patients and young physicians alike ÃÆ'Ã'¢Ã¢'Ã'¬" under your careÃÆ'Ã'¢Ã¢'Ã'¬Ã'Ã'¦"

April 2003 Collaborative Leadership in Action Award for HIV/HCV Coinfection, Rhode Island NonProfit Resources

December 2008 2008 Red Ribbon Community Service Award
Dr. Alvan Fisher Medical Service Award
For help, support and commitment to HIV/AIDS work and AIDS Project Rhode Island

March 2010 Clinical Infectious Diseases Award for Outstanding Review

Affiliations

MEMBERSHIP IN SOCIETIES
1997 - American Medical Association
1997 - American College of Physicians, American Society of Internal Medicine
2011 - Elected to Fellowship in the American College of Physicians
1997 - Rhode Island Medical Women's Association
1998 - Rhode Island Medical Society
2002 - HIV Medicine Association of the Infectious Disease Society of America
2005 - American Association for the Study of Liver Diseases (AASLD)
2011 - Member, AASLD Hepatitis C Special Interest Group
2008 - International AIDS Society (IAS)
2012 Academy of Breastfeeding Medicine
2014- National Viral Hepatitis Roundtable

OTHER APPOINTMENTS

1986 ââ'¬" 1987 New England Women's Health Center, Brookline, MA Health Educator/Contraceptive Counselor
1989 ââ'¬" 1991 Commonwealth of Massachusetts Office of the District Attorney,
Cambridge, MA
Victim Witness Advocate/Crisis Intervention Counselor
1991 ââ'¬" 1993 Massachusetts Department of Public Health, Boston, MA
Bureau of Health Statistics, Research and Evaluation Occupational Fatality Surveillance Project Coordinator

2005 Abstract Reviewer
2005 National HIV Prevention Conference, Atlanta GA

2005 - Managing Physician, Sunrise House, Providence, RI
(Rhode Island's only HIV/AIDS assisted living establishment)

2005 - Managing Physician, AIDS Care Ocean State Adult Services
(Rhode Island's only Community Based Organization solely dedicated to the care of persons with and at risk of HIV infection)

2006 - 2008 Member, Editorial Board, Infectious Disease in Corrections Report
www.idcronline.org

2006 Grant Reviewer
University of California, Universitywide AIDS Research Program, Applied Clinical/Health Services Research Study Section, Ad-Hoc Member

2007 Teaching Faculty
Hepatitis C University, http://www.hcvu.org/intro, a project of Organization to Achieve Solutions in Substance Abuse (O.A.S.I.S), Oakland, CA and the California Society of Addiction Medicine (CSAM) .

2007 Electronic Grant Reviewer
National Institute on Drug Abuse "Cutting Edge Basic
Research Award Program" (CEBRA)

2007 Faculty
HCV Treatment in the Setting of Methadone Maintenance: Management Tools for Healthcare Professionals. Clinical Care Options, Hepatitis.

2008 - 2011 Member, Medical Advisory Committee
American Liver Foundation New England Chapter

2009 Manuscript Reviewer, Field Reviewer
Center for Substance Abuse Treatment (CSAT)
Knowledge Application Program, Treatment Improvement Protocol (TIP): Addressing Viral Hepatitis in People with Substance Use Disorders

2009 - Reviewer, Infectious Diseases specialty at UpToDate
http://www.uptodate.com

2010 - 2011 Member, Data Safety Monitoring Board, NIH Center for AIDS Research (CFAR) Study, "Optimizing Men's Sexual Health in a High Risk Environment."

2010 Member, Hepatitis C Consultation Meeting, 2010 Ryan White Grantee Meeting & 13th Annual Clinical Conference, 20 Years of Leadership: A Legacy of Care. Presented by the Health Resources and Services Administration HIV/AIDS Bureau. August 25, 2010
Washington, DC.

2010 - Investigator, AIDS Clinical Trials Group (ACTG) Study Monitoring Committee of the Hepatitis Transformative Science Group

2010 - Expert Advisory Panel: CARE. Seek & Treat NIH R01 (CARE Corrections: Technology for Jail HIV/HCV Testing, Linkage, and Care)

2011 Editorial Panel, A Guide for Evaluation and Treatment of Hepatitis C in Adults Coinfected with HIV. Health Resources and Services Administration's HIV/AIDS Bureau, Authors Mark S. Sulkowski, Laura W. Cheever, David H. Spach

2011 Committee Member, National Institute of Mental Health Special Emphasis Panel, HIV Prevention in MSM. March 10, 2011

2011 - Co-Director, Lifespan/Tufts/Brown Center for AIDS Research (CFAR) HIV and Substance Abuse Working Group.

2011 - 2013 Executive Committee Member, TNC-CDAAR, Tufts, Brown, Johns Hopkins Center for Drug Abuse and AIDS Research

2011 Symposium Co-Chair, "Hepatitis C Virus: The Changing Paradigm. Sponsored by Brown Alpert Medical School; Tufts University School of Medicine; Lifespan/Tufts/Brown Center for AIDS Research; TNC-CDAAR, Tufts, Brown, Johns Hopkins Center for Drug Abuse and AIDS Research; Brown University AIDS Program. April 27, 2011, Providence, RI.

2011 - Executive Committee Member, Lifespan/Tufts/Brown CFAR

2011 - 2012 Member, Perinatal Hepatitis Group, Division of Gastroenterology, Brown University, Providence, RI

2011 Medical Reviewer, "HIV, Hepatitis C and You: A Guide for Coinfected People," TheBody.com, The Complete HIV/AIDS Resource

Fall 2011- Consultant, Prison HepC Working Group, The Center for Prisoner Health and Human Rights, Miriam Hospital/Brown University Medical School

2011 - 2013 International Consensus Guidelines Committee Member, Management of HCV in People who Use Drugs, International Network of Hepatitis in Substance Users.

2012 - Investigator, ACTG Site 2951

October 2012- Expert, Hepatitis and HIV Coinfection Forum
TheBody.Com

February 25, 2013 NIDA Grant Reviewer, PAR10-099 Collaborative Clinical Trials in Drug Abuse (Collaborative R01). Examination of a Multicomponent Intervention to Increase HCV evaluation and Treatment Engagement of HCV-infected Methadone Maintenance Patients

May 2013 Abstract Reviewer
3rd International Symposium on Hepatitis Care in Substance Users, International Network on Hepatitis in Substance Users, Munich, Germany, September 5-6, 2013.

June 2013- Advisor, Second Meeting of the Guideline Development Group to develop World Health Organization Standard Guidelines for Screening, Care and Treatment of Chronic Hepatitis C Virus (HCV) Infection. Geneva, Switzerland, 24-26 June 2013

Fall 2013 - Symposium Chair, "Treating and Defeating Hep C in Rhode Island." Sponsored by RI Defeats Hep C and Warren Alpert Medical School of Brown University, in collaboration with Lifespan/Tufts/Brown Center for AIDS Research. May 16, 2014. Providence, RI.

January 2014 - Working group member, CFAR Network of Integrated Clinical Systems (CNICS) 078, "Hepatitis C treatment uptake and predictors of HCV therapy among HIV-infected individuals in the era of direct-acting antiviral agents." In addition to the objectives of the concept proposal, the goal is to identify areas that will allow us to collaboratively improve our CNICS platform to facilitate future HCV and liver- related research.
MANUSCRIPT REVIEWER
2003, 2005, 2008, 2010, 2012, 2013 Clinical Infectious Diseases
2003, 2007 Journal of Infectious Diseases
2006 Annals of Internal Medicine
2008 Gastroenterology
2009 AIDS Reader
2010, 2013 Journal of Acquired Immune Deficiency Syndromes
2010 Journal of Viral Hepatitis
2011 The Open Infectious Diseases Journal
2013 Journal of Clinical Gastroenterology
2013 Virulence

Funded Research

Ongoing Support

1. Department of Health and Human Services, SAMHSA, Center for Substance Abuse Treatment 1H79TI024721-01 Hurley (PI) 07/01/13-06/30/14
HCV Screening and Referral: Rhode Island Testing to Treatment Project (HT2T)
The purpose of this program is to address the high prevalence of HCV among people who inject drugs in selected opioid treatment programs. In addition to providing rapid HCV testing, applicants must develop a plan for providing referrals for care and treatment that include, but are not limited to primary health care, public health, mental health, and medical services for those who are HCV-infected or are at high-risk of HCV infection.
Role: Consulting Physician

2. Rhode Island Innovation Fellowship Taylor 05/07/13-12/31/15
Rhode Island Defeats Hep C http://www.ridefeatshepc.com
Rhode Island Defeats Hepatitis C is a comprehensive program to Seek, Test, Treat, Cure and Eliminate hepatitis C virus infection in Rhode Island. Rhode Island Innovation Fellows receive up to $300,000 over three years to develop, test, and implement innovative ideas that have the potential to dramatically improve any area of life in Rhode Island.

3. Lifespan Seed Funding Grant Program Proposal Taylor (PI) 09/01/12-08/31/14
“Neurocognitive and Brain Benefits of HCV Eradication in HIV/HCV Coinfectionâ€Ã'
The goal of the proposed research is to determine whether eradication of the HCV virus through antiviral therapy leads to improved neurocognitive and structural and metabolic brain abnormalities, in HIV/HCV coinfected persons.

4. AIDS Care Ocean State Taylor (PI) 12/01/05-
“HIV and Hepatitis Community Collaboration.â€Ã'
This project was established to enhance the provision of HIV and viral hepatitis health services, prevention and care to Rhode Islanders living with or at risk of these infections.

Completed Research Support

1. P30DA013868 Gorbach (PI) 09/20/08-08/31/13
NIH/NIDA
“Center for Drug Abuse and AIDS Research (CDAAR)â€Ã'
Role: Co-Director, Hepatitis and Liver Function Core, Core G
The Brown-Tufts CDAAR aims to enhance basic, clinical, epidemiological, prevention and applied research on drug abuse and HIV infection through the support of shared resources. The Hepatitis and Liver Disease Core was implemented to stimulate and facilitate research on HIV, drug abuse, viral hepatitis and resultant liver disease. The Core also provides education, training, and outreach.

2. K23 DA020383-01 Taylor (PI) 07/01/08-06/30/13
NIH/NIDA
“Buprenorphine as a Bridge to HCV Treatment for HIV/HCV Coinfected Opioid Users.â€Ã'
The goals of this research were to explore the impact of drug use on the ability of HIV/HCV coinfected individuals to engage in HCV treatment; to design and implement studies to improve health services delivery for HIV/HCV coinfected drug users; and to develop treatment interventions to limit morbidity and mortality of those at highest risk for HCV disease progression.

3. Rhode Island Breastfeeding Coalition Taylor (PI) on behalf of MomDocFamily, Office of Women in Medicine and Science, Brown University 09/13/10-06/30/13
Two mini-grants are awarded to implement the Business Case for Breastfeeding in Rhode Island, to enhance lactation support for physicians and nurses at Miriam and Rhode Island Hospitals.

4. “Make it HAPPEN in Rhode Island: Hepatitis Awareness, Prevention, Policy and Education Networkâ€Ã' Taylor (PI) 05/01/06- 02/29/12
Roche Pharmaceuticals through 2008 then supported by AIDS Care Ocean State CBO
This grant established Rhode Island’s first hepatitis C and B testing, counseling, hepatitis A and B vaccination and referral sites targeting injection drug users and other at-risk populations.

5. 1R21 DA028645 Merchant (PI) 03/01/10-02/29/12 NIH/NIDA
“Increasing Viral Testing in the Emergency Department (InVITED)â€Ã'
The major goal of this research was to identify unrecognized HIV, hepatitis B, and hepatitis C infections among drug misusers through combined rapid screening in the emergency department.
Role: Co-Investigator

6. Lifespan/Tufts/Brown Center for AIDS Research Taylor (PI) 10/15/07-01/14/10
“Screening for Acute Hepatitis C Virus Among At Risk HIV+ Populations.â€Ã'
The aims of this pilot study were to develop, implement and evaluate a screening strategy for acute HCV infection among at-risk patients in an HIV clinic based on risk factors and ALT and to estimate acute HCV incidence.

7. Rhode Island Foundation Medical Research Grant Taylor (PI) 02/01/07-01/31/10
“Identifying Acute Hepatitis C Virus among At-Risk-Hard-to-Reach Populations.â€Ã'
The aim of this study was to examine the feasibility of identifying acute hepatitis C virus at a men’s bathhouse.

8. Roche Labs, Inc Taylor (PI) 09/19/05-01/14/09
“Caring for HIV/Hepatitis C at Methadone Programs (CHAMP).â€Ã'
The aim of this pilot study was to explore the feasibility of utilizing weight-based ribavirin and supervised pegylated interferon/ribavirin dosing to improve sustained virologic response rates in HIV/HCV coinfected patients on methadone compared to historical controls from the AIDS Clinical Trial Group 5071.

9. 1H79TI15875 Rich (PI) 09/30/03-09/29/08
CSAT/SAMHSA
“Substance Abuse Treatment and HIV/AIDS Services (Project VISTA).â€Ã'
The goal of this project was to provide substance abuse treatment and pre-treatment services to people with or at risk for HIV.
Role: Evaluator

10. NIAAA 5R01AA007850-17 Monti (PI) 01/01/06-07/31/07
“Biobehavioral Mechanisms of Topiramate and Drinking.â€Ã'
This project provided a comprehensive analysis of the effects of topiramate on drinking and craving and new information about putative biobehavioral mechanisms of topiramate’s effects.
Role: Study Physician

11. Trial 1100.1448 Taylor (PI) 11/24/04-01/17/07
Boehringer-Ingelheim
“Pharmacokinetics of nevirapine in hepatically-impaired patients.â€Ã'
This study assessed nevirapine levels in HIV-infected patients with hepatic impairment to determine whether nevirapine requires dosing adjustment in this population.
Role: Principal Investigator, Rhode Island site

12. Developmental Grant Taylor (PI) 09/11/02-03/31/03
Lifespan Hospitals
“Pilot Study to evaluate a multidisciplinary treatment and support program to treat hepatitis C in patients coinfected with HIV.â€Ã'
The goal of this project was to design, implement and evaluate a pilot intervention to treat hepatitis C with interferon-based therapy in HIV/HCV coinfected persons with comorbid substance and psychiatric disorders.

13. KD1 TI12037-03 Rich (PI) 02/15/00-02/14/03
CSAT/SAMHSA
“Physician Patient IDU Pilot Program.â€Ã'
This goal of this project was to determine whether physician syringe prescription decreased transmission of HIV and viral hepatitis.
Role: Project Physician

Teaching Experience

UNIVERSITY TEACHING ROLES
2002-2008 Preceptor, Brown Medical School Hepatitis C Community Health Clerkship

2002 Summer Research Assistantship
"Hepatitis A and B Vaccination among HIV/HCV Coinfected Patients"

2003-2005 Preceptor, Brown Medical School, Infectious Disease Elective
"HIV/HCV Coinfection"

2003 Preceptor, Brown Medical School, Independent Study Project
"HIV/HCV Coinfection"

2003 Preceptor, Undergraduate Summer Clinical Experience

2003-present Interviewer for Residency Programs in Medicine, Brown University School of Medicine

2004-2011 Mentor, Brown University Women in Medicine Mentor Program

2005-2006 Mentor, Brown Medical School, Residency Programs in Medicine, Community 2010-2011 Based Teaching Program, Immunology Center, Miriam Hospital, Providence,
RI (One clinic session per week)

March 25-29, 2007. Mentor, Harvard Career Internship Program, Spring Recess Internship on HIV/AIDS, Immunology Center, Miriam Hospital, Providence, RI.

2006-present Faculty, Roger Williams Medical Center/Boston University School of Medicine Infectious Disease Fellowship Program. HIV/Viral Hepatitis Coinfection Clinic.

May 7, 2007 Faculty Lecturer, "Viral Hepatitis A-E," Bio 365 Combined Microbiology, Infectious Disease and Pharmacology. The Warren Alpert Medical School of Brown University.

2007-2012 Mentor, Doctoring Course I & II. The Warren Alpert Medical School of Brown University.

April 9, 2008 Faculty Lecturer, "Viral Hepatitis A-E," Bio 365: Integrated Medical Sciences II. Microbiology/Infectious Diseases. The Warren Alpert Medical School of Brown University.

2008-2011 Preceptor, Brown Meds-Peds Residency Independent Study Project
ACTG Sub analysis, "The incidence of acute hepatitis C virus infection in American men who have sex with men, 2000-2008."

2008-2010 Preceptor, Gastroenterology Fellow Independent Study Project
"The Spectrum of Undiagnosed Chronic Hepatitis C Virus in an HIV Clinic."

April 3, 2009 Faculty Lecturer, "Viral Hepatitis I and II, A-E," Biology 3656 Integrated Medical Sciences II: Microbiology/Infectious Diseases. The Warren Alpert Medical School of Brown University.

2009-2012 Project Mentor, "Hepatocellular Carcinoma in HIV/HCV Infected Women," MGH Institute of Health Professions, Boston, MA, Graduate Program in Clinical
Investigation, Master of Science Degree in Clinical Investigation Project.

2009-2012 Mentor, T32 Fellowship on HCV
Project Mentor, "Hepatitis C: The Burden of Silent Disease among HIV-infected Men who have Sex with Men at a Boston Community Health Center."

May- Preceptor, Yale School of Public Health Summer Internship
Aug 2009 "HCV Treatment for Coinfected Patients on Opioid Replacement Therapy."

March 26, 2010 Faculty Lecturer, "Viral Hepatitis I and II, A-E," Biology 3653 University
Integrated Medical Sciences Microbiology/Infectious Diseases/Pharmacology. The Warren Alpert Medical School of Brown University.

March 25, 2011 Faculty Lecturer, "Viral Hepatitis I and II, A-E," Biology 3653 University
Integrated Medical Sciences Infectious Disease Pathophysiology, Microbiology and Pharmacology. The Warren Alpert Medical School of Brown University

2011- CDAAR Project Mentor, "Phosphodiesterase type 5 inhibitors: Potential role in
the sexual transmission of HCV infection amongst HIV-infected men who have sex with men."

2011- Hepatitis B Community Screening Project Mentor

2011- CDAAR Project Mentor, "HIV/HCV and Pulmonary Hypertension."

2012- Center for Prisoner Health and Human Rights, Miriam Hospital and Brown Medical School, Departmental Independent Study Project Mentor, "Developing a Hepatitis C Policy for RI."

March 29, 2012 Faculty Lecturer, "Viral Hepatitis I and II," The Infectious Diseases, Microbiology and Anti-infective Pharmacology course at the Warren Alpert Medical School (BIOL 3653 IMS-II). Providence, RI. The Warren Alpert Medical School of Brown University

July 2012 - Mentor, Tufts Infectious Disease Research Fellowship

HOSPITAL TEACHING ROLES
2000 - 2003 Immunology Center/HIV Clinic Attending, Miriam Hospital, Providence, RI
(Two clinic sessions per week)
2005 - present (One clinic session per week)

2000 - 2002 Immunology Center/HIV Clinic Inpatient Service, Miriam Hospital, Providence, RI
(Approximately ten weeks per year)
2008- present (Approximately six-eight weeks per year)

Longitudinal Rotation, Immunology Center, Miriam Hospital, Providence, RI
(One clinic session per week)
2002 - 2003
2008 - 2009
2010 - 2011
2011
2012 - 2013

2003- present HIV/Viral Hepatitis Coinfection Clinic Preceptor to Brown University Gastroenterology Fellows (One-two clinic sessions per month)

2003- present HIV/Viral Hepatitis Coinfection Clinic Preceptor to Infectious Disease Fellows, Brown University Infectious Disease Fellowship

2008-2010 HIV/HCV Coinfection Clinic Preceptor to T-32 Fellows

INVITED PRESENTATIONS
1. Invited Speaker, "Delivering Care to HIV/HCV Coinfected Drug Users and Marginalized Populations." NIH/NIDA/NIDDK Conference, Hepatitis C Infection and Substance Abuse: Medical Management and Developing Models of Integrated Care, Washington, DC. November 12, 2003.
2. Invited Speaker, "HIV/Hepatitis C Coinfection: An Overview." Gastroenterology Grand Rounds, Brown Medical School, RI Hospital, Providence, RI. December 11, 2003.
3. Invited Speaker, "HCV Care for HIV-seropositive Patients." ACTG Clinical Trials working group, Miriam Hospital, Providence, RI. September 2, 2004.
4. Invited Speaker, "HIV/HCV Coinfection: An Overview." Presented to Case managers for HIV-infected Persons in Rhode Island, Austin Place, Pawtucket, RI. October 21, 3003.
5. Invited Speaker, "Developing a Program to Treat Hepatitis C Among HIV-infected Drug Users with Comorbid Psychiatric Illness." Center for AIDS Research (CFAR) Seminar, Providence, RI. December 5, 2003.
6. Invited Speaker, "Delivering Hepatitis C Care to HIV/HCV Coinfected Populations: An Update." Infectious Disease Conference, Brown Medical School, Providence, RI. March 18, 2004.
7. Invited Speaker, "Update on Hepatitis C Treatment." The Rhode Island Chapter of the Association of Nurses in AIDS Care, Providence, RI. April 7, 2004.
8. Invited Speaker, "Treating Hepatitis C in the Patient Coinfected with HIV." Gastroenterology Conference, Baystate Medical Center, Springfield, MA. April 21, 2004.
9. Invited Speaker, "Viral Hepatitis." Medicine Residents' Noon Conference Lecture Series, Miriam Hospital, Brown Medical School, Providence, RI. May 12, 2004.
10. Invited Speaker, "Hepatitis C in the Setting of HIV: Treatment Update." Infectious Disease Conference, Greater New Bedford Health Center, New Bedford, MA. May 26, 2004.
11. Invited Speaker, "Viral Hepatitis." Medicine Residents' Noon Conference Lecture Series, Rhode Island Hospital, Brown Medical School, Providence, RI. May 27, 2004.
12. Invited Speaker, "Hepatitis." Infectious Disease Fellowship Lecture Series, Rhode Island Hospital, Brown Medical School, Providence, RI. June 4, 2004.
13. Invited Speaker, "HIV/HCV Consensus Guidelines: Controversies in the Management of Hepatitis C in the Setting of HIV." Clinical AIDS Task Force Series, Brown University AIDS Program, Miriam Hospital, Brown Medical School, Providence, RI. August 5, 2004.
14. Invited Speaker, "HIV and Hepatitis C Coinfection: Diagnosis and treatment in correctional and post-correctional settings." Inside and Out: HIV and Corrections Conference 2004. The HIV Health Institute, Boston AIDS Action Committee, Plymouth, MA. October 20, 2004.
15. Invited Lecturer, "Foundations of Human Diseases III: Viral Hepatitis." University of Rhode Island, College of Pharmacy, Kingston, RI. December 6, 2004.
16. Invited Speaker, "Viral Hepatitis in the Setting of HIV." Lifespan/Tufts/Brown Center for AIDS Research (CfAR), Brown Medical School, Providence, RI. December 10, 2004.
17. Invited Speaker, "Physician Update on HIV/HCV Co-infection." Brown University AIDS Program, Rhode Island Department of Corrections, Cranston, RI. August 15, 2005.
18. Invited Speaker, "HIV/Hepatitis C Coinfection Treatment Update." Center for Treatment and Recovery, Pawtucket, RI. September 29, 2005.
19. Invited Speaker, "HIV/Hepatitis C Coinfection Treatment Update." Metro Treatment, Providence, RI. November 1, 2005.
20. Invited Speaker, "HIV/Hepatitis C Coinfection Treatment Update." Center for Behavioral Health, Johnston, RI. October 6, 2005.
21. Invited Speaker, "Hepatitis: Pathophysiology and Treatment." Foundations in Human Disease III, Pharmacotherapeutics II, Infectious and Pulmonary Diseases. University of Rhode Island School of Pharmacy. Kingston, RI. November 7, 2005.
22. Invited Speaker, "Viral Hepatitis." Infectious Disease Fellowship Lecture Series, Rhode Island Hospital, Brown Medical School, Providence, RI. December 16, 2005.
23. Invited Speaker, "HIV/Hepatitis C Coinfection Update." Austin Place, Pawtucket, RI. January 17, 2006.
24. Invited Speaker, "Caring for HIV/HCV Coinfected Persons on Methadone Maintenance Therapy." Discovery House, Providence, RI. February 17, 2006.
25. Invited Speaker, "HIV/Hepatitis C: An Overview." Creating Bridges to Care: A Regional Conference on HIV, Hepatitis and Substance Use. Jointly sponsored by Brown Center for AIDS Research (CfAR), AIDS Action Committee of Massachusetts, Rhode Island Department of Mental Health and Retardation, AIDS Project Rhode Island, Latin American Health Institute, Massachusetts Bureau of Substance Abuse Services, New England HIV Education Consortium. March 22, 2006.
26. Invited Speaker, "Hep C: Why Should HIV+ Persons Be Treated?" Ryan White HIV Clinic, Plymouth, MA. April 12, 2006.
27. Invited Speaker, "Hepatitis C and Methadone Maintenance." CODAC Behavioral Health Inc. Annual Meeting, Cranston, RI. April 26, 2006.
28. Invited Speaker, "Hepatitis C Care for HIV+ Persons: Myths and Realities." AGAPE Center, Woonsocket, RI. May 10, 2006.
29. Invited Speaker, "Barriers to Care in the Community: Special Emphasis on Addictions." 9th Lemuel Shattuck Hospital HIV Conference. Progress and Challenges: HIV 2006. John F. Kennedy Library and Museum, Columbia Point, Boston, MA. June 16, 2006.
30. Invited Speaker, "HIV/HCV Coinfection: Treating Substance Users – Addressing the Challenges." RI Association of Nurse in AIDS Care. Providence, RI. June 28, 2006.
31. Invited Speaker, "Hepatitis C Testing and Treatment: What You Need to Know." Family Services, Woonsocket, RI. October 17, 2006.
32. Invited Speaker, "Viral Hepatitis A, B, C, D, E: Pathophysiology and Treatment." Foundations in Human Disease, Pharmacotherapeutics, Infectious Diseases. University of Rhode Island School of Pharmacy. Kingston, RI. November 6, 2006.
33. Invited Speaker, "Hepatitis B, Hepatitis C, and HIV Co-infection: Diagnosis, Treatment and Side Effect Management." Rhode Island Department of Corrections, Adult Probation and Parole. Cranston, RI. November 8, 2006.
34. Invited Speaker, "Viral Hepatitis in the Setting of HIV: Current Research Efforts and Future Directions." Division of Gastroenterology Research Conference, Brown Medical School, Rhode Island Hospital, Providence, R.I. February 7, 2007.
35. Invited Speaker, "Liver Disease in HIV-Seropositive Patients." Division of Gastroenterology Case Management Conference, Brown Medical School, Rhode Island Hospital, Providence, R.I. March 9, 2007.
36. Invited Speaker, "MomDocFamily: Creating Contacts, Community and Connections for Physician Mothers." Transforming Academic Medicine Through Women's Leadership Conference, Office of Women in Medicine and the Brown University/Women & Infants Hospital National Center of Excellence in Women's Health. Bryant University, Smithfield, R.I. May 3, 2007.
37. Invited Speaker, "Chronic Hepatitis C in HIV Coinfected Patients: Our Current Understanding and Management." HIV-Hepatitis Satellite Symposium at the American Conference for the Treatment of HIV (ACTHIV). Hyatt Regency Dallas, Texas. June 2, 2007.
38. Invited Speaker, "Hepatitis C in 2007: What You Need to Know." Discovery House, Providence, RI. August 2, 2007.
39. Invited Speaker, "Chronic Hepatitis C Virus in HIV Coinfected Patients: Time to Deliver." Rhode Island Hospital Continuing Medical Education Department of Medicine, Division of Infectious Disease, Infectious Disease Conference. Miriam Hospital, Providence, RI. August 22, 2007.
40. Invited Speaker, "Viral Hepatitis A-E Complete." Foundations in Human Disease, Pharmacotherapeutics, Infectious Diseases Core Lectures. University of Rhode Island School of Pharmacy. Kingston, RI. November 30, 2007.
41. Invited Speaker, "Acute Hepatitis C for People Living with HIV: A Threat…and Some Potential Directions." AIDS Project Rhode Island. Providence, RI. December 17, 2007.
42. Invited Speaker, "Screening, Diagnosis and Treatment of Chronic Hepatitis C Infection." Thundermist Health Center, Woonsocket, RI. February 14, 2008.
43. Invited Speaker, "Advances in the Treatment of HIV/HCV Coinfection." HIV/AIDS Case Managers Training, Providence, RI. February 15, 2008.
44. Invited Speaker, "Screening, Diagnosis and Treatment of Chronic Hepatitis C Virus Infection." Discovery House, Providence, RI. April 3, 2008.
45. Invited Speaker, "Atypical Presentation of Liver Disease in the Setting of HIV Infection." Gastroenterology Grand Rounds, Alpert Medical School of Brown University, RI Hospital, Providence, RI. May 8, 2008.
46. Invited Speaker, "Atypical Presentation of Liver Disease in the Setting of HIV Infection." Brown University AIDS Program, Clinical AIDS Task Force Series, Alpert Medical School of Brown University, Miriam Hospital, Providence, RI. June 5, 2008.
47. Invited Speaker, Skills Building Workshop, "Global HIV/HCV Coinfection: Barriers to HCV Treatment and Models of Integrated HIV/HCV Care." AIDS 2008: XVII International AIDS Conference, Mexico City, Mexico, August 4, 2008.
48. Invited Speaker, "2008 IAS Conference Update," Clinical AIDS Task Force Series, Brown University AIDS Program, Miriam Hospital, Brown Medical School, Providence, RI. September 3, 2008.
49. Invited Speaker, "Contraception for HIV+ Individuals," Clinical AIDS Task Force Series, Brown University AIDS Program, Miriam Hospital, Brown Medical School, Providence, RI. October 1, 2008.
50. Invited Speaker, "Occult Hepatitis B and Seronegative Hepatitis C Viremia in HIV-Infected and Uninfected Women," Lifespan/Tufts/Brown Center for AIDS Research (CFAR) Research-In-Progress Seminar, Miriam Hospital, Warren Alpert Medical School at Brown University, Providence, RI. November 21, 2008.
51. Invited Speaker, "Viral Hepatitis A-E Complete." Foundations in Human Disease, Pharmacotherapeutics, Infectious Diseases Core Lectures. University of Rhode Island School of Pharmacy. Kingston, RI. November 23, 2008.
52. Invited Speaker, "Rare Bird or Emerging Epidemic of Liver Disease amongst HIV-Infected Individuals: Sexually Transmitted Acute HCV." Division of Gastroenterology Case Management Conference, Brown Medical School, Rhode Island Hospital, Providence, R.I. March 13, 2009.
53. Invited Speaker, "Mothering and Doctoring: A conversation about how and when they overlap." The Office of Women in Medicine, MomDocFamily, Brown University, Providence, R.I. April 6, 2009.
54. Invited Speaker, "Screening, Diagnosis and Treatment of Hepatitis C." Discovery House, Providence, RI. May 7, 2009.
55. Invited Speaker, "Viral Hepatitis." Infectious Disease Fellowship Lecture Series, The Warren Alpert Medical School of Brown University, Rhode Island Hospital, Providence, RI. May 29, 2009.
56. Invited Speaker, "Rare Bird or Emerging Epidemic of Liver Disease Amongst HIV-Infected Individuals." Rhode Island & Miriam Hospitals Continuing Medical Education, Department of Medicine, Division of Infectious Diseases, Infectious Disease Conference. The Warren Alpert Medical School of Brown University. Miriam Hospital. Providence, RI. June 4, 2009.
57. Invited Speaker, "Advances in the Treatment of HCV/HIV Coinfection." Rhode Island Free Clinic, Providence, RI. July 22, 2009.
58. Invited Speaker, "Rare Bird or Emerging Epidemic of Liver Disease amongst HIV-Infected Individuals." Medical Staff Meeting, Fenway Health, Boston, MA. September 9, 2009.
59. Invited Speaker, "Hepatitis C among New England Men Who have Sex with Men." Centers for Disease Control and Prevention, Division of Viral Hepatitis, Acute Hepatitis C Virus Infection among HIV-Infected Men Who Have Sex with Men: Organizing a Research Consortium to Study an Emerging Public Health Problem. Boston, MA, October 29, 2009.
60. Invited Speaker, "Viral Hepatitis A-E Complete." PHP/BPS 409 Foundations of Human Disease III & PHP 413 Pharmacotherapeutics of Infectious Diseases and Pulmonary Disorders, University of Rhode Island School of Pharmacy. Kingston, RI. October 30, 2009.
61. Invited Speaker, "Successful Strategies to Overcome Challenges in the Evaluation and Treatment of HCV in Patients on Opiate Agonist Therapy." Interface Between Hepatology, Infectious Diseases, and Addiction Medicine: Treatment of Hepatitis C Virus in Patients on Opiate Agonist Treatment. Weill Cornell Medical College, New York, NY, November 13, 2009.
62. Invited Speaker, "Is Hep C a sexually transmitted disease?" Living Well Gay Men's Health Update 2009, The Fenway Institute | Fenway Health, Boston, MA, November 23, 2009.
63. Invited Speaker, "Hepatitis B: An Overview." Infectious Disease Fellowship Lecture Series, The Warren Alpert Medical School of Brown University, Rhode Island Hospital, Providence, RI. December 18, 2009.
64. Invited Speaker, "The Role of Advocacy in Hepatitis C Prevention and NEPs." Brown Physicians for Human Rights, The Warren Alpert Medical School of Brown University, Biomedical Center, Providence, RI. January 8, 2010.
65. Invited Speaker, "Love your Liver," on behalf of the American Liver Foundation. Lunch and Learn, Nayatt School, Barrington, RI. January 21, 2010.
66. Invited Speaker, "Acute HCV Infection among HIV+ Individuals: Research Efforts and Next Steps." Division of Gastroenterology Research Conference, Brown Medical School, Rhode Island Hospital, Providence, R.I. April 28, 2010.
67. Invited Speaker, "The Hepatitis C Drug Pipeline: Small Molecules, Big Revolution?" Rhode Island & Miriam Hospitals Continuing Medical Education, Department of Medicine, Division of Infectious Diseases, Infectious Disease Conference. The Warren Alpert Medical School of Brown University. Miriam Hospital. Providence, RI. May 20, 2010.
68. Invited Speaker, "Screening and Treatment Goals for Patients Infected with HCV/HIV Coinfection." Discovery House, Woonsocket, RI. May 27, 2010.
69. Invited Speaker, "Hepatitis C Virus and HIV/HCV Coinfection Update." Health Care Grand Rounds, State of Rhode Island and Providence Plantations, Department of Corrections Health Care Services. Cranston, RI. June 10, 2010.
70. Invited Speaker, "Acute Hepatitis C Virus Infection Among HIV-Infected Men Who Have Sex With Men: Research Efforts And Next Steps." CFAR Research-In-Progress Lecture Series, Miriam Hospital, Providence, RI. September 3, 2010.
71. Invited Speaker, "The Hepatitis C Drug Pipeline: Lessons learned from development of antiretroviral therapy for HIV." Division of Gastroenterology Pathophysiology Conference, Brown Medical School, Rhode Island Hospital, Providence, RI. November 18, 2010.
72. Invited Speaker, "Viral Hepatitis C and B Basics." Department of Emergency Medicine Research Training Session, Warren Alpert Medical School, Brown University, Rhode Island Hospital, Providence, RI. November 22, 2010.
73. Invited Speaker, "Viral Hepatitis A-E Complete." PHP/BPS 409 Foundations of Human Disease III & PHP 413 Pharmacotherapeutics of Infectious Diseases and Pulmonary Disorders, University of Rhode Island School of Pharmacy. Kingston, RI. December 6, 2010.
74. Invited Speaker, "The Role of Advocacy in Hepatitis C Prevention and Care." The Warren Alpert Medical School of Brown University Student Chapter of Physicians for Humans Rights. Biomedical Center. Providence, RI. January 19, 2011.
75. Invited Speaker, "Mothering and Doctoring: A conversation about how and when they overlap." MomDocFamily, The Office of Women in Medicine and Science, The Warren Alpert Medical School of Brown University. Providence, RI. February 3, 2011.
76. Invited Speaker, "The Hepatitis C Drug Pipeline and AASLD 2010 Update:
Lessons Learned from Development of Antiretroviral Therapy for HIV." Thundermist Health Center, Woonsocket, RI. February 8, 2011.
77. Invited Speaker, "Screening and Treatment Goals for Patients with HCV/HIV Coinfection." AIDS Care Ocean State Community Based Organization. Providence, RI. February 17, 2011.
78. Invited Speaker, "Alleviating the Global Burden of Disease due to Hepatitis B." Team Hepatitis B Collegiate Chapter, MacMillan Hall, Brown University. April 20, 2011. Brown University, Providence, RI.
79. Invited Speaker, "Genetic Determinants in HCV." Symposium, Hepatitis C Virus: The Changing Paradigm. Warren Alpert Medical School of Brown University, Tufts Nutrition Collaborative - Center for Drug Abuse and AIDS Research, Lifespan/Tufts/Brown Center For AIDS Research (CFAR), Brown University AIDS Program (BRUNAP). Providence, RI. April 27, 2011.
80. Invited Speaker, "Recent Presentations and Research on HCV, HIV/HCV and Alcohol." Brown Center for Alcohol and Addiction Studies, Brown University, Providence, RI. June 16, 2011.
81. Invited Speaker, "Epidemiology and new aspects of treatment of HIV in substance users." 2nd International Symposium on Hepatitis Care in Substance Users. Brussels, Belgium. September 16, 2011.
82. Invited Speaker, "Viral Hepatitis C and B Basics." Department of Emergency Medicine Research Training Session, Warren Alpert Medical School of Brown University, Rhode Island Hospital, Providence, RI. December 8, 2011.
83. Invited Speaker, "Viral Hepatitis A-E Complete." PHP 413 Pharmacotherapeutics of Infectious Diseases and Pulmonary Disorders and PHP 409 Pathophysiology of Infectious Diseases and Pulmonary Disorders. University of Rhode Island School of Pharmacy. Kingston, RI. December 12, 2011.
84. Invited Speaker, "Myth Busters: Overcoming Misperceptions about Hepatitis C Virus Infection." Department of Medicine, Division of Infectious Disease Friday Lecture Series, The Warren Alpert Medical School of Brown University, Hasbro Hospital, Providence, RI. January 20, 2012.
85. Invited Speaker, "Hepatitis C and Public Policy." Infectious Disease Interest Group. Brown Alpert Medical School. Providence, RI. March 29, 2012.
86. Invited Speaker, "Substance abuse and readiness for HCV treatment." Harvard University Center for AIDS Research (HU CFAR) 2012 Annual Symposium, "HIV/HCV 2012: Advances in Research and Treatment." Joseph B. Martin Conference Center at Harvard Medical School, 77 Avenue Louis Pasteur, Boston, MA. April 26, 2012.
87. Invited Speaker, "Substance abuse and readiness for HCV treatment." Rhode Island & Miriam Hospitals Continuing Medical Education, Department of Medicine, Division of Infectious Diseases, Infectious Disease Conference. The Warren Alpert Medical School of Brown University. Miriam Hospital. Providence, RI. June 14, 2012.
88. Invited Speaker, "Time to change the rules? Eradicating hepatitis C virus in drug-involved HIV-infected populations." Nutrition/Infection Unit, Department of Public Health and Community Medicine, Tufts University School of Medicine, Monthly Division Conference, Boston, MA. October 10, 2012.
89. Invited Speaker, "Hot Topic: Pharmacotherapies for hepatitis C virus infection." Brown Alcohol Research Center on HIV (ARCH) Annual Retreat, Center for Alcohol and Addiction Studies, Brown University, Providence, RI. October 22, 2012
90. Invited Panelist, "Clinical Trial Design: IDUs and HCV clinical trials," 9th HCV Drug Development Advisory Group (DrAG) Meeting, Forum for Collaborative HIV Research, November 8, 2012. Fenway Health, Boston, MA.
91. Invited Speaker, "Viral Hepatitis A-E Complete." PHP/BPS 409 Foundations of Human Disease III & PHP 413 Pharmacotherapeutics of Infectious Diseases and Pulmonary Disorders, University of Rhode Island School of Pharmacy. Kingston, RI. December 3, 2012.
92. Invited Speaker, "Hepatitis C on World AIDS Day." Providence RED, Providence Mayor's Office. Biltmore Hotel, Providence, RI. December 3, 2012.

93. Invited Speaker, "HIV 101," Pathways to Healthy Housing Conference, AIDS Care Ocean State, Biltmore Hotel, Providence, RI. April 2, 2013.
94. Co-Leader, Brown University Division of Infectious Diseases Journal Club, "Biomarkers of Inflammation and Coagulation Are Associated With Mortality and Hepatitis Flares in Persons Coinfected with HIV and Hepatitis Viruses." Rhode Island Hospital, Providence, RI. April 5, 2013

Selected Publications

  • Robaeys G, Grebely J, Mauss S, Bruggmann P, Moussalli J, De Gottardi A, Swan T, Stover H, Wedemeyer H, Schaefer M, Taylor LE, Backmund M, Prins M, Dore GJ. Recommendations for the management of hepatitis C virus infection among people who inject drugs. Accepted for publication, Clin Infect Dis, publication date August 2013. (2013)
  • Grebely J, Oser M, Taylor LE, Dore GJ. Breaking Down the Barriers to Hepatitis C Virus (HCV) Treatment Among Individuals With HCV/HIV Coinfection: Action Required at the System, Provider, and Patient Levels. J Infect Dis 2013 Mar;207 Suppl 1:S19–25. doi: 10.1093/infdis/jis928. PMID: 23390301 (2013)
  • Westbrook ML, Garg S, Chapman S, Cu-Uvin S, Tashima KT, Taylor LE. Hepatocellular Carcinoma in HIV-Infected Women: Two Case Reports. Rhode Island Medical Journal. 2013 Jan;96(1):21-24. (2013)
  • Garg S, Taylor LE, Grasso C, Mayer KH. Prevalent and Incident Hepatitis C Virus Infection among HIV-Infected Men Who Have Sex with Men Engaged in Primary Care in a Boston Community Health Center. Clin Infect Dis. 2013 Feb 5. [Epub ahead of print] PMID: 23386630. (2013)
  • Taylor LE, Swann T, Matthews G. Management of HCV/HIV co-infection among people who use drugs in the era of DAA-based therapy. Accepted for publication, Clin Infect Dis, publication date August 2013. (2013)
  • Taylor LE, Maynard MA, Friedmann PD, Macleod CJ, Rich JD, Flanigan TP, Sylvestre DL. Buprenorphine for Human Immunodeficiency Virus/Hepatitis C Virus-coinfected Patients: Does It Serve as a Bridge to Hepatitis C Virus Therapy? J Addict Med. 2012 Sep;6(3):179-85. PMID: 22614935 (2012)
  • Taylor LE, Swan T, Mayer KH. HIV coinfection with hepatitis C virus: evolving epidemiology and treatment paradigms. Clin Infect Dis. 2012 Jul;55 Suppl 1:S33-42. PMID: 22715212 (2012)
  • Blackard JT, Ma G, Welge JA, Martin C, Sherman KE, Taylor LE, Mayer KH, Jamieson DJ. Analysis of a non-structural gene reveals evidence of possible hepatitis C virus (HCV) compartmentalization. J Med Virol. 2012 Feb;84(2):242-52. PMID: 22170544 (2012)
  • MacNamara MM, Moren K, Taylor LE, Taylor JS. State-wide support for physician-mothers who are breastfeeding. Med Health RI. 2012 Jan;95(1):9-13. PMID: 22439455 (2012)
  • MacNamara MM, Taylor JS, Grimm KJ, Taylor LE, Gottlieb, AS. Using a professional organization, MomDocFamily, to understand the lives of physician-mothers. Med Health RI. 2012 Jun;95(6):189-93. PMID: 22866508 (2012)
  • Rich JD, Wohl DA, Beckwith CG, Spaulding AC, Lepp NE, Baillargeon J, Gardner A, Avery A, Altice FL, Springer S; Centers for AIDS Research—Collaboration on HIV in Corrections (CFAR-CHIC) Working Group. Taylor LE, Collaborator. HIV-related research in correctional populations: now is the time. Curr HIV/AIDS Rep. 2011 Dec;8(4):288-96. PMID: 21904902 (2011)
  • Taylor LE, Bowman SE, Chapman S, Zaller N, Stein MD, Cioe P, Maynard M, McGovern BH. Treatment for hepatitis C virus genotype 1 infection in HIV-infected individuals on methadone maintenance therapy. Drug Alcohol Depend. 2011 Jul 1;116(1-3):233-7. Epub 2010 Dec 21. PMID: 21177046 (2011)
  • Taylor LE, Gaitanis MM, Beckwith CG. Commentary: A Call for Routine HIV Testing Among Patients with Hepatitis C Virus Infection. The Open Infectious Diseases Journal. 2011 June 29;5:19-20 doi: 10.2174/1874279301105010019 (2011)
  • Taylor LE, Holubar M, Wu K, Bosch RJ, Wyles DL, Davis JA, Mayer KH, Sherman KE, Tashima KT. Incident hepatitis C virus infection among US HIV-infected men enrolled in clinical trials. Clin Infect Dis. 2011 Mar 15;52(6):812-8. Epub 2011 Jan 31. PMID: 21282184 (2011)
  • Blackard JT, Welge JA, Taylor LE, Mayer KH, Klein RS, Celentano DD, Jamieson DJ, Gardner L, Sherman KE. HIV mono-infection is associated with FIB-4 - A noninvasive index of liver fibrosis - in women. Clin Infect Dis. 2011 Mar 1;52(5):674-80. Epub 2011 Jan 19. PMID: 21248367. (2011)
  • Taylor LE, DeLong AK, Maynard MA, Chapman S, Gholam P, Blackard JT, Rich J, Mayer KH. Acute hepatitis C virus in an HIV clinic: a screening strategy, risk factors, and perception of risk. AIDS Patient Care STDs. 2011 Oct;25(10):571-7. Epub 2011 Aug 22. PMID: 21859307 (2011)
  • Blackard JT, Ma G, Limketkai BN, Welge JA, Dryer PD, Martin CM, Hiasa Y, Taylor LE, Mayer KH, Jamieson DJ, Sherman KE. Variability of the polymerase gene (NS5B) in hepatitis C virus-infected women. J Clin Microbiol. 2010 Nov;48(11):4256-9. Epub 2010 Sep 1. PMID: 20810773 (2010)
  • Rich JD, Taylor LE. The beginning of a new era in understanding hepatitis C virus prevention. J Infect Dis. 2010 Oct 1;202(7):981-3. PMID: 20726769. (2010)
  • Tate DF, Conley J, Paul RH, Coop K, Zhang S, Zhou W, Laidlaw DH, Taylor LE, Flanigan T, Navia B, Cohen R, Tashima K. Quantitative diffusion tensor imaging tractography metrics are associated with cognitive performance among HIV-infected patients. Brain Imaging Behav. 2010 Mar;4(1):68-79. Epub 2010 Jan 19. PMID: 20503115 (2010)
  • Dryer PD, Limketkai BN, Martin CM, Ma G, Sherman KE, Taylor LE, Mayer KH, Jamieson DJ, Blackard JT. Screening for hepatitis C virus non-nucleotide resistance mutations in treatment naïve women. Journal of Antimicrobial Chemotherapy 2009 Nov;64(5):945-8. PMID: 19767319 (2009)
  • Taylor LE. HIV/viral hepatitis coinfection: the Immunology Center experience. Med Health R.I. 2009 Jul;92(7):234-6. PMID: 19685638 (2009)
  • Chew KW, Allen SA, Taylor LE, Rich JD, Feller E. Treatment outcomes with pegylated interferon and ribavirin for male prisoners with chronic hepatitis C. J Clin Gastroenterol. 2009 Aug;43(7):686-91. PMID: 19295448 Erratum in: J Clin Gastroenterol. 2009 Nov-Dec;43(10):1010. (2009)
  • Taylor LE, Mayer KH. Acute hepatitis c virus infection in an HIV clinic and in community settings. Gastroenterology 2009 Jun;136(7):2411-2. PMID: 19409986 (2009)
  • Bräu N, Fox RK, Xiao P, Marks K, Naqvi Z, Taylor LE, Trikha A, Sherman M, Sulkowski MS, Dieterich DT, Rigsby MO, Wright TL, Hernandez MD, Jain MK, Khatri GK, Sterling RK, Bonacini M, Martyn CA, Aytaman A, Llovet JM, Brown ST, Bini EJ; North American Liver Cancer in HIV Study Group. Presentation and outcome of hepatocellular carcinoma in HIV-infected patients; a U.S.-Canadian multicenter study. J Hepatol. 2007 Oct;47(4):527-37. PMID: 17692986 (2007)
  • Brim N, Zaller N, Taylor LE, Feller E. Twinrix vaccination schedules among injecting drug users. Expert Opin Bio. Ther. 2007 Mar;7(3):379-89. PMID: 17309329 (2007)
  • Lai AR, Tashima KT, Taylor LE. Antiretroviral medication considerations for individuals coinfected with HIV and hepatitis C virus. AIDS Patient Care STDS. 2006 Oct;20(10):678-92. PMID: 17052138 (2006)
  • McGovern BH, Ditelberg JS, Taylor LE, Gandhi RT, Christopoulos KA, Chapman S, Schwartzapfel B, Rindler E, Fiorino AM, Zaman MT, Sax PE, Graeme-Cook F, Hibberd PL. Hepatic steatosis is associated with fibrosis, nucleoside analogue use, and hepatitis C virus genotype 3 infection in HIV-seropositive patients. Clin Infect Dis. 2006 Aug 1;43(3):365-72. PMID: 16804853 (2006)
  • Blackard JT, Komurian-Pradel F, Perret M, Sodoyer M, Smeaton L, St. Clair JB, Chapman S, Taylor LE, Paranhos-Baccalà G, Chung RT. Intrahepatic cytokine expression is downregulated during HCV/HIV co-infection. J Med Virol. 2006 Feb;78(2):202-07. PMID: 16372286 (2006)
  • Taylor LE, Gholam PM, Schwartzapfel B, Rich JD. Hepatitis C treatment in an HIV-HCV-coinfected patient with drug addiction and psychiatric illness: a case report. AIDS Read. 2005 Nov; 5(11):629-31,634-6,638. PMID: 16323305 (2005)
  • Flanigan TP, Taylor LE, Mitty JA. Use of community-based, directly observed therapy for HIV infection: lessons learned for treatment of hepatitis C virus infection. Clin Infect Dis. 2005 Apr 15;40 Suppl 5:S346-8. PMID: 15768346 (2005)
  • Taylor LE. Delivering care to injection drug users coinfected with HIV and hepatitis C virus. Clin Infect Dis. 2005 Apr 15;40 Suppl 5:S355-61. PMID: 15768348 (2005)
  • Macalino GE, Hou JC, Kumar MS, Taylor LE, Sumantera IG, Rich JD. Hepatitis C infection and incarcerated populations. Int'l J Drug Pol. 2004 Apr;15(2):103-14. (2004)
  • Stozek MA, Taylor LE, LeBreux L, Olson J, Wolf F, Rich JD. Prescribing syringes to injection drug users with HIV: an important clinical and public health tool. J Assoc Nurses AIDS Care. 2004 Mar-Apr;15(2):59-63. PMID: 15090134 (2004)
  • Rich JD, McKenzie M, Macalino GE, Taylor LE, Sanford-Colby S, Wolf F, McNamara S, Mehrotra M, Stein MD. A syringe prescription program to prevent infectious disease and improve health of injection drug users. J Urban Health. 2004 Mar;81(1):122-34. PMID: 15047791 (2004)
  • Rich JD, Taylor L, Mehrotra M, Mason R, Stozek M, Stancliff S. Prescribing syringes to injection drug users: what the family physician should know. Am Fam Physician. 2003 Jul 1;68(1):45-7. PMID: 12887113 (2003)
  • Allen SA, Spaulding AC, Osei AM, Taylor LE, Cabral AM, Rich JD. Treatment of chronic hepatitis C in a state correctional facility. Ann Intern Med. 2003 Feb 4;138(3):187-90. PMID: 12558357 (2003)
  • Taylor LE, Runarsdottir V, Zampi A, Osei A, Sanford S, Macalino G, McKenzie M, Burris S, Gross M, Reinert S, Rich JD. Would you consider prescribing syringes to injection drug users? Addiction Medicine Conference Survey. J Addict Dis. 2003;22(1):67-78. PMID: 12661980 (2003)
  • Rich JD, Martin EG, Macalino GE, Paul RV, McNamara S, Taylor LE. Pharmacist support for selling syringes without a prescription to injection drug users in Rhode Island. J Am Pharm Assoc (Wash). 2002 Nov-Dec;42(6 Suppl 2):S58-61. PMID: 12489617 (2002)
  • Taylor LE, Costello T, Alt E, Yates G, Tashima K. Psychiatric illness and illicit drugs as barriers to hepatitis C treatment among HIV/hepatitis C virus co-infected individuals. AIDS. 2002 Aug16;16(12):1700-1. PMID: 12172100 (2002)
  • Rich JD, Macalino GE, McKenzie M, Taylor LE, Burris S. Syringe prescription to prevent HIV infection in Rhode Island: a case study. Am J Public Health. 2001 May;91(5):699-700. PMID: 11344871 (2001)